Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01327898 · ClinicalTrials.gov registry record · Phase 2

Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)

A Phase 2 study, sponsored by Nova Southeastern University.

Completed
Registry status
Phase 2
Development phase
515
Enrollment target

NCT01327898 is a Phase 2 study that has completed, run by Nova Southeastern University. The registered enrollment target is 515 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01327898, a Phase 2 study, has completed, sponsored by Nova Southeastern University.

COMPLETED
Registry status
Phase 2
Development phase
515 participants
Enrollment target

Study Summary

The specific aims of the 5-year study are to: 1) describe the nature and extent of substance use and sexual risk behaviors in a sample of 500 sexually active, substance using, not-in-treatment men who have sex with men (MSM) in urban South Florida (Miami/Ft. Lauderdale); 2) identify the independent covariates of baseline substance abuse and sexual risks; 3) evaluate, through random assignment of participants, the relative effectiveness of two intervention conditions in reducing sexual risks and substance use, as measured at 3-, 6-, and 12-month follow-up assessments: a) an innovative five-session risk reduction intervention derived from psychological empowerment theory titled Project GOAL; and, b) an enhanced community standard-of-care HIV counseling Comparison Condition.

Interventions

  • BEHAVIORAL empowerment theory-based small group discussion
  • BEHAVIORAL individual resilience counseling

Trial Details

FieldValue
Enrollment Target 515 participants
Start Date 2008-11
Est. Completion 2014-07
Phase Phase 2

Sponsor

Nova Southeastern University

71 total trials

What the Registry Record Tells You About NCT01327898

The ClinicalTrials.gov registry entry for NCT01327898 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 515 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which empowerment theory-based small group discussion is the first listed.

NCT01327898 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01327898 about?

NCT01327898 is a clinical study titled "Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)". The specific aims of the 5-year study are to: 1) describe the nature and extent of substance use and sexual risk behaviors in a sample of 500 sexually active, substance using, not-in-treatment men who have sex with men (MSM) in urban South Florida (Miami/Ft. Lauderdale); 2) identify the independent ...

What is the current status of trial NCT01327898?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 515 participants. The study started on 2008-11. Estimated completion is 2014-07.

What interventions are being tested in trial NCT01327898?

The interventions under investigation include: empowerment theory-based small group discussion (BEHAVIORAL), individual resilience counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01327898?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.